Reporting scoping reviews—PRISMA ScR extension

      Researchers are recommended to use PRISMA-ScR when reporting their scoping review findings.
      To read this article in full you will need to make a payment

      References

        • Glasziou P.
        • Meats E.
        • Heneghan C.
        • Shepperd S.
        What is missing from descriptions of treatment in trials and reviews?.
        BMJ. 2008; 336: 1472-1474
        • Hoffmann T.
        • English T.
        • Glasziou P.
        Reporting of interventions in randomised trials: an audit of journal instructions to authors.
        Trials. 2014; 15: 20
        • Simera I.
        • Moher D.
        • Hirst A.
        • Hoey J.
        • Schulz K.F.
        • Altman D.G.
        Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network.
        BMC Med. 2010; 8: 24
        • Song F.
        • Parekh S.
        • Hooper L.
        • Loke Y.K.
        • Ryder J.
        • Sutton A.J.
        • et al.
        Dissemination and publication of research findings: an updated review of related biases.
        Health Technol Assess. 2010; 14: 1-193
        • Altman D.G.
        • Simera I.
        Using reporting guidelines effectively to ensure good reporting of health research.
        in: Moher D. Altman D. Schulz K. Simera I. Wager E. Guidelines for Reporting Health Research: A User's Manual. J Wiley, Hoboken, NJ2014
      1. Higgins J.P.T. Thomas J. Chandler J. Cumpston M. Li T. Page M.J. Cochrane Handbook for Systematic Reviews of Interventions version 6.0. Cochrane, 2019 (Available at)
        www.training.cochrane.org/handbook
        Date accessed: February 17, 2020
        • Aromataris E.
        • Munn Z.
        Joanna Briggs Institute Reviewer’s Manual.
        The Joanna Briggs Institute, 2017 (https://wiki.joannabriggs.org/display/MANUAL/JBI+Reviewer%27s+Manual. Accessed February 17, 2020.)
        • Centre for Reviews and Dissemination
        Systematic reviews: CRD’s guidance for undertaking reviews in health care.
        Centre for Reviews and Dissemination, York2009 (Available at)
        • Altman D.
        • Simera I.
        • Hoey J.
        • Moher D.
        • Schulz K.
        EQUATOR: reporting guidelines for health research.
        Open Med. 2008; 2: e49
      2. Enhancing the QUAlity and transparency of health research (EQUATOR) network.
        (Available at)
        https://www.equator-network.org
        Date accessed: February 7, 2020
        • Brouwers M.C.
        • Kerkvliet K.
        • Spithoff K.
        The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines.
        BMJ. 2016; 352: i1152
        • Ogrinc G.
        • Davies L.
        • Goodman D.
        • Batalden P.
        • Davidoff F.
        • Stevens D.
        SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process.
        BMJ Qual Saf. 2016; 25: 986-992
        • IICoMJ
        Preparing a Manuscript for Submission to a Medical Journal.
        (Available at)
        • Zuniga-Hernandez J.A.
        • Dorsey-Trevino E.G.
        • Gonzalez-Gonzalez J.G.
        • Brito J.P.
        • Montori V.M.
        • Rodriguez-Gutierrez R.
        Endorsement of reporting guidelines and study registration by endocrine and internal medicine journals: meta-epidemiological study.
        BMJ Open. 2019; 9: e031259
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • Altman D.G.
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        J Clin Epidemiol. 2009; 62: 1006-1012
        • Tricco A.C.
        • Lillie E.
        • Zarin W.
        • O'Brien K.K.
        • Colquhoun H.
        • Levac D.
        • et al.
        PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation.
        Ann Intern Med. 2018; 169: 467-473
        • Welch V.
        • Petticrew M.
        • Petkovic J.
        • Moher D.
        • Waters E.
        • White H.
        • et al.
        Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
        J Clin Epidemiol. 2016; 70: 68-89
        • Welch V.
        • Petticrew M.
        • Tugwell P.
        • Moher D.
        • O'Neill J.
        • Waters E.
        • et al.
        PRISMA-Equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity.
        PLoS Med. 2012; 9: e1001333
        • Beller E.M.
        • Glasziou P.P.
        • Altman D.G.
        • Hopewell S.
        • Bastian H.
        • Chalmers I.
        • et al.
        PRISMA for Abstracts: reporting systematic reviews in journal and conference abstracts.
        PLoS Med. 2013; 10: e1001419
        • Moher D.
        • Shamseer L.
        • Clarke M.
        • Ghersi D.
        • Liberati A.
        • Petticrew M.
        • et al.
        Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
        Syst Rev. 2015; 4: 1
        • Stewart L.A.
        • Clarke M.
        • Rovers M.
        • Riley R.D.
        • Simmonds M.
        • Stewart G.
        • et al.
        Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement.
        JAMA. 2015; 313: 1657-1665
        • Hutton B.
        • Salanti G.
        • Caldwell D.M.
        • Chaimani A.
        • Schmid C.H.
        • Cameron C.
        • et al.
        The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
        Ann Intern Med. 2015; 162: 777-784
        • Zorzela L.
        • Loke Y.K.
        • Ioannidis J.P.
        • Golder S.
        • Santaguida P.
        • Altman D.G.
        • et al.
        PRISMA harms checklist: improving harms reporting in systematic reviews.
        BMJ. 2016; 352: i157
        • Guise J.M.
        • Butler M.E.
        • Chang C.
        • Viswanathan M.
        • Pigott T.
        • Tugwell P.
        AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist.
        J Clin Epidemiol. 2017; 90: 43-50
        • McInnes M.D.F.
        • Moher D.
        • Thombs B.D.
        • McGrath T.A.
        • Bossuyt P.M.
        • Clifford T.
        • et al.
        Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
        JAMA. 2018; 319: 388-396
        • Tricco A.C.
        • Lillie E.
        • Zarin W.
        • O'Brien K.
        • Colquhoun H.
        • Kastner M.
        • et al.
        A scoping review on the conduct and reporting of scoping reviews.
        BMC Med Res Methodol. 2016; 16: 15
        • Miake-Lye I.M.
        • Hempel S.
        • Shanman R.
        • Shekelle P.G.
        What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and products.
        Syst Rev. 2016; 5: 28
        • Hoxha M.
        A systematic review on the role of eicosanoid pathways in rheumatoid arthritis.
        Adv Med Sci. 2018; 63: 22-29
        • Bourne A.M.
        • Johnston R.V.
        • Cyril S.
        • Briggs A.M.
        • Clavisi O.
        • Duque G.
        • et al.
        Scoping review of priority setting of research topics for musculoskeletal conditions.
        BMJ Open. 2018; 8: e023962
        • Solloway M.R.
        • Taylor S.L.
        • Shekelle P.G.
        • Miake-Lye I.M.
        • Beroes J.M.
        • Shanman R.M.
        • et al.
        An evidence map of the effect of Tai Chi on health outcomes.
        Syst Rev. 2016; 5: 126
      3. The PRISMA-ScR (PRISMA extention for scoping reviews).
        (Available at)